Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience - PubMed (original) (raw)
Clinical Trial
Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience
Maretta De Ioris et al. Eur J Cancer. 2008 Mar.
Abstract
Aim of the study: To investigate the characteristics of patients with hepatoblastoma and low serum alpha-fetoprotein (AFP) at diagnosis.
Patients and methods: Inclusion of all 21 patients accrued onto SIOPEL trials, whose serum AFP was <100ng/ml at diagnosis. Slides of all 15 patients with available histological material were centrally reviewed.
Results: Median age: 10 months. Disease extension at diagnosis: PRETEXT group: II (3 patients), III (10 patients) and IV (8 patients). Extra-hepatic extension: 8 patients. Multifocal tumour: 8 patients. Histology at review: wholly epithelial subtype: 11/15 patients including nine with a small-cell undifferentiated histology.
Outcome: only 9 patients achieved a partial response and 16 died. Median survival: 4.4 months. Two-year overall survival: 24% (confidence interval 10-45%).
Conclusion: This study clearly identifies patients with hepatoblastoma and low serum AFP at diagnosis as a high-risk subgroup with extensive disease at diagnosis, poor response to chemotherapy and a poor outcome.
Similar articles
- Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN, Park M, Kim BE, Bae KW, Kim KM, Im HJ, Seo JJ. Koh KN, et al. Pediatr Blood Cancer. 2011 Oct;57(4):554-60. doi: 10.1002/pbc.23069. Epub 2011 Mar 2. Pediatr Blood Cancer. 2011. PMID: 21370433 - Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, Superina RA. Browne M, et al. J Pediatr Surg. 2008 Nov;43(11):1973-81. doi: 10.1016/j.jpedsurg.2008.05.031. J Pediatr Surg. 2008. PMID: 18970927 - Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
Semeraro M, Branchereau S, Maibach R, Zsiros J, Casanova M, Brock P, Domerg C, Aronson DC, Zimmermann A, Laithier V, Childs M, Roebuck D, Perilongo G, Czauderna P, Brugieres L. Semeraro M, et al. Eur J Cancer. 2013 Mar;49(4):915-22. doi: 10.1016/j.ejca.2012.10.003. Epub 2012 Nov 9. Eur J Cancer. 2013. PMID: 23146961 - Fetal and neonatal hepatic tumors.
Isaacs H Jr. Isaacs H Jr. J Pediatr Surg. 2007 Nov;42(11):1797-803. doi: 10.1016/j.jpedsurg.2007.07.047. J Pediatr Surg. 2007. PMID: 18022426 Review. - Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.
Ayllon Teran D, Gómez Beltran O, Ciria Bru R, Mateos González E, Peña Rosa MJ, Luque Molina A, López Cillero P, Briceño Delgado J. Ayllon Teran D, et al. World J Gastroenterol. 2014 Aug 7;20(29):10137-43. doi: 10.3748/wjg.v20.i29.10137. World J Gastroenterol. 2014. PMID: 25110441 Free PMC article. Review.
Cited by
- Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.
Nguyen R, McCarville MB, Sykes A, Mao S, Wu J, Langham MR Jr, Furman WL. Nguyen R, et al. Int J Clin Oncol. 2018 Oct;23(5):900-907. doi: 10.1007/s10147-018-1285-4. Epub 2018 May 9. Int J Clin Oncol. 2018. PMID: 29744604 - Abdominal pain and distension in a 4-years-old child revealing an hepatoblastoma.
Berrada K, El Ouali I, El Harass Y, Belkouchi L, Allali N, Chat L, El Haddad S. Berrada K, et al. Radiol Case Rep. 2024 Sep 12;19(12):5804-5808. doi: 10.1016/j.radcr.2024.07.185. eCollection 2024 Dec. Radiol Case Rep. 2024. PMID: 39308612 Free PMC article. - Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.
Zheng C, Ye S, Liu W, Diao M, Li L. Zheng C, et al. Front Oncol. 2023 Oct 13;13:1276175. doi: 10.3389/fonc.2023.1276175. eCollection 2023. Front Oncol. 2023. PMID: 37901310 Free PMC article. - Liver tumors in children with chronic liver diseases.
Sintusek P, Phewplung T, Sanpavat A, Poovorawan Y. Sintusek P, et al. World J Gastrointest Oncol. 2021 Nov 15;13(11):1680-1695. doi: 10.4251/wjgo.v13.i11.1680. World J Gastrointest Oncol. 2021. PMID: 34853643 Free PMC article. Review. - Chloroquine Triggers Cell Death and Inhibits PARPs in Cell Models of Aggressive Hepatoblastoma.
Eloranta K, Cairo S, Liljeström E, Soini T, Kyrönlahti A, Judde JG, Wilson DB, Heikinheimo M, Pihlajoki M. Eloranta K, et al. Front Oncol. 2020 Jul 17;10:1138. doi: 10.3389/fonc.2020.01138. eCollection 2020. Front Oncol. 2020. PMID: 32766148 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials